NCT06939738

Brief Summary

The ASSIST clinical study is an observational, multicenter study to assess the performance of a cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, developed to detect Acute Myocardial Infarction (AMI). The main objectives are to compare Willem™ performance to detect and triage ECG patterns associated with AMI compared with human ECG interpretation, and to assess the time periods for both approaches.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
489

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2025

Geographic Reach
2 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
Last Updated

July 20, 2026

Status Verified

July 1, 2026

Enrollment Period

1.2 years

First QC Date

April 15, 2025

Last Update Submit

July 17, 2026

Conditions

Keywords

Acute Myocardial Infarction (AMI)STEMINSTEMIOcclusion Myocardial Infarction (OMI)AI-based ECG analysis

Outcome Measures

Primary Outcomes (1)

  • Device performance

    Assessment of Willem™ diagnostic performance to detect Acute Myocardial Infarction (AMI) based on ECG analysis. The diagnostic performance metrics and their measurement units will be: * Accuracy, Sensitivity, and Specificity (%) * Positive Predictive Value (PPV) and Negative Predictive Value (NPV) (%) * F1-score (score from 0.0 to 1.0)

    At the time of enrolment and throughout the baseline visit (single study visit)

Secondary Outcomes (1)

  • Time assessment

    At the time of enrolment and throughout the baseline visit (single study visit)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with suspected Acute Coronary Syndrome (ACS) presenting to the emergency department and subsequently referred for angiography at the Catheterization Laboratory of the participating sites.

You may qualify if:

  • Age ≥ 18 years;
  • Available digitally stored 12-lead ECG traces prior to invasive coronary angiography;
  • Available angiographic and clinical data.

You may not qualify if:

  • ECGs with poor signal quality;
  • Lack of digitally stored 12-lead ECG traces prior to coronary angiography;
  • Previous coronary events (AMI, coronary revascularizations);
  • Non-available clinical or angiographic data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Unidade Local de Saúde de São José

Lisbon, 1169-056, Portugal

Location

Unidade Local de Saúde de Lisboa Ocidental

Lisbon, 1449-005, Portugal

Location

Germans Trias i Pujol University Hospital

Barcelona, 08916, Spain

Location

Hospital General Universitario Gregorio Marañón

Madrid, 28007, Spain

Location

La Paz University Hospital

Madrid, 28046, Spain

Location

MeSH Terms

Conditions

ST Elevation Myocardial InfarctionNon-ST Elevated Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Alfonso Jurado, MD, PhD

    La Paz University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2025

First Posted

April 23, 2025

Study Start

April 1, 2025

Primary Completion

June 15, 2026

Study Completion

June 30, 2026

Last Updated

July 20, 2026

Record last verified: 2026-07

Locations